Money
– Chairman and CEO Phillip Frost: From an R&D perspective, all our programs are progressing. – – – Opko Health Inc. (NYSE: OPK; TASE: OPK) reported higher...
Hi, what are you looking for?
– Chairman and CEO Phillip Frost: From an R&D perspective, all our programs are progressing. – – – Opko Health Inc. (NYSE: OPK; TASE: OPK) reported higher...
– Teva will receive $72 million from future sales or from the proceeds of an exit, if any. Diapep277 Slowing the Progression of Type 1...
– GlaxoSmithKline and BioRap will commercialize a treatment for lethal side effects of bone marrow transplants. – – Pharmaceutical giant GlaxoSmithKline plc (LSE: GSK)...
– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation. – In the coming weeks, several Israeli...
– Insulin tablet developer Oramed Pharmaceuticals has published a draft prospectus. – – Insulin tablet developer Oramed Pharmaceuticals Inc. (Nasdaq:ORMP) has published a draft prospectus to...
– Israel is in talks with the world’s space agencies to add an Israeli astronaut on a manned space mission in the coming years....
– Quark, which develops drugs for eye diseases, is launching new ventures in India and China Quark Pharmaceuticals Inc. (formerly QBI), which attempted an IPO...
– The laser surgical devices company plans to hold the IPO in the first quarter of 2014. – Lumenis Ltd., a developer of...
– The Momentum Fund hopes to invest in 20-40 projects in the first quarter of 2014 in pharmaceuticals, healthcare, high-tech and physical sciences. –...
– The medical devices company plans to raise the money at a company valuation of $500 million by February. – – Sources inform ”Globes”...